Skip to main content

Table 1 Events and timeline of the disease course in patient one in co-infection of HIV and SARS-CoV-2

From: New HIV diagnoses in patients with COVID-19: two case reports and a brief literature review

Hospitalization Day1 Day2 Day3 Day4 Day5 Day6 Day7 Day8 Day9 Day10 Day11 Day12 Day13 Day14 Day15 Day16 Day17 Day18 Day19 Day20 Day21 Day22 Day23 Day24 Day25 Day26 Day27 Day28 Day29 Day49
Fever, °C 36.5 37 37 37 37 38.5 37.4 37.2 38 37 37.1 37.1 40 36.8 36.7 37 36.6 37 36.5 36.5 36.5 36.5 36.6 37 37.2 36.8 37.2 36.4 36.5  
Nasopharyngeal swabs            N           N N         
WBC counts, ×109/L   6.3       5.0       6.9     4.3       7.8       
Lymphocyte, × 109/L   1.08       1.16       1.20     0.70       1.31       
Platelet, × 1012/L   285       273       272     249       210       
CRP, mg/L   39.71                       0.29       
Procalcitonin, ng/ml   0.03                 0.01       0.02       
Albumin, g/L   38.2       36.2           33.1     32.7   32.5       
Interlukin-6, pg/mL              30.54        688.40      521.00      
SARS-CoV-2 IgG                63.52           3.87      
SARS-CoV-2 IgM                30.12           0.96      
CD4 T cells/μL                          13      
imaging findings      GGO        GGO,         GGO,      GGO,,some become solic      
HIV viral load (copies/mL)                               1.7 × 105
  1. Abbreviations: COVID-19 Coronavirus disease 2019; CRP C-reactive protein; GGO Ground-glass opacities; HIV Human immunodeficiency virus; IgM Immunoglobulin M; WBC White blood cell; N Negative